Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

Clinical trial NCT01236391 · COMPLETED

Trial details

NCT number: NCT01236391
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2011-02-01
Primary completion: 2014-01-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.